Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07731308
NA

Zirconia-Reinforced Glass Ionomer Versus Injectable Giomer in Class V Restorations

Sponsor: Cairo University

View on ClinicalTrials.gov

Summary

This randomized controlled clinical trial aims to compare the clinical performance of zirconia-reinforced glass ionomer and injectable giomer restorations in Class V carious lesions among controlled type II diabetic against non-diabetics. One hundred Class V restorations will be allocated equally into four parallel groups according to restorative material and diabetic status. Clinical performance will be evaluated at baseline, 6, 12, and 18 months using the modified United States Public Health Service (USPHS) criteria. The primary outcome is restoration retention, while secondary outcomes include marginal adaptation, marginal discoloration, secondary caries, and postoperative sensitivity.

Official title: Clinical Performance of Zirconia-Reinforced Glass Ionomer Versus Injectable Giomer in Class V Restorations of Diabetic and Non Diabetic Patients: 18 Months Controlled Clinical Trial

Key Details

Gender

All

Age Range

22 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2027-01

Completion Date

2029-01

Last Updated

2026-07-28

Healthy Volunteers

No

Interventions

OTHER

Zirconomer

Zirconia-reinforced glass ionomer restorative material (SHOFU)

OTHER

Beautifil Flow Plus X

Injectable giomer restorative material incorporating S-PRG technology (SHOFU)